Cinctive Capital Management LP Spring Works Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$36.06 - $47.62 $1.21 Million - $1.6 Million
33,592 Added 34.65%
130,545 $4.92 Million
Q1 2024

May 15, 2024
BUY
$36.5 - $52.5 $1.03 Million - $1.47 Million
28,091 Added 40.79%
96,953 $4.77 Million
Q4 2023

Feb 14, 2024
BUY
$18.94 - $37.24 $1.3 Million - $2.56 Million
68,862 New
68,862 $2.51 Million

Others Institutions Holding SWTX

# of Institutions
238
Shares Held
69.8M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email